• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型糖尿病早期肾病患者接受1年抗高血压治疗后左心室肥厚的消退情况。

Regression of left ventricular hypertrophy with 1 year of antihypertensive treatment in type 1 diabetic patients with early nephropathy.

作者信息

Sampson M J, Chambers J B, Sprigings D C, Drury P L

机构信息

Department of Diabetes, Kings College Hospital, London, UK.

出版信息

Diabet Med. 1991 Feb-Mar;8(2):106-10. doi: 10.1111/j.1464-5491.1991.tb01554.x.

DOI:10.1111/j.1464-5491.1991.tb01554.x
PMID:1827393
Abstract

M-mode echocardiograms were recorded in 22 Type 1 diabetic patients with microalbuminuria (n = 10) or early persistent proteinuria (n = 12). Eight (36%) had both an increased left ventricular mass (males greater than 131 g m-2; females greater than 100 g m-2) and a systolic blood pressure above the 75th centile of the normal blood pressure distribution. These eight patients were treated with antihypertensive drugs, predominantly enalapril, for 1 year. Echocardiograms were repeated after 3 and 12 months. Systolic blood pressure at recruitment was 155 +/- 14 (+/- SD) mmHg, and was significantly lower after 3 months (146 +/- 12 mmHg; p less than 0.05) and 12 months (139 +/- 8 mmHg; p less than 0.005). Diastolic blood pressure did not change significantly. Both intraventricular septal width and left ventricular posterior wall thickness fell progressively and were significantly lower after 12 months treatment (15.0 +/- 2.7 vs 13.0 +/- 2.6 mm, and 10.3 +/- 1.9 vs 8.8 +/- 1.3 mm; both p less than 0.05). Left ventricular mass index was 148 +/- 29 g m-2 at recruitment, but lower after 3 months (131 +/- 25 g m-2; p less than 0.05) and 12 months (132 +/- 26 g m-2; p less than 0.005) antihypertensive therapy.

摘要

对22例1型糖尿病伴微量白蛋白尿(n = 10)或早期持续性蛋白尿(n = 12)的患者进行了M型超声心动图检查。其中8例(36%)患者既有左心室质量增加(男性大于131 g/m²;女性大于100 g/m²),又有收缩压高于正常血压分布的第75百分位数。这8例患者接受了以依那普利为主的降压药物治疗1年。在3个月和12个月后重复进行超声心动图检查。入组时收缩压为155±14(±标准差)mmHg,3个月后(146±12 mmHg;p<0.05)和12个月后(139±8 mmHg;p<0.005)显著降低。舒张压无显著变化。室间隔宽度和左心室后壁厚度均逐渐下降,治疗12个月后显著降低(分别为15.0±2.7 vs 13.0±2.6 mm,以及10.3±1.9 vs 8.8±1.3 mm;p均<0.05)。入组时左心室质量指数为148±29 g/m²,但在降压治疗3个月后(131±25 g/m²;p<0.05)和12个月后(132±26 g/m²;p<0.005)降低。

相似文献

1
Regression of left ventricular hypertrophy with 1 year of antihypertensive treatment in type 1 diabetic patients with early nephropathy.1型糖尿病早期肾病患者接受1年抗高血压治疗后左心室肥厚的消退情况。
Diabet Med. 1991 Feb-Mar;8(2):106-10. doi: 10.1111/j.1464-5491.1991.tb01554.x.
2
Intraventricular septal hypertrophy in type 1 diabetic patients with microalbuminuria or early proteinuria.1型糖尿病合并微量白蛋白尿或早期蛋白尿患者的室间隔肥厚。
Diabet Med. 1990 Feb;7(2):126-31. doi: 10.1111/j.1464-5491.1990.tb01346.x.
3
Cardiac hypertrophy in diabetic nephropathy: an echocardiographic study.糖尿病肾病中的心脏肥大:一项超声心动图研究。
Diabet Med. 1988 Dec;5(9):840-4. doi: 10.1111/j.1464-5491.1988.tb01121.x.
4
Prevalence of left ventricular hypertrophy in Type I diabetic patients with diabetic nephropathy.I型糖尿病肾病患者左心室肥厚的患病率。
Diabetologia. 1999 Jan;42(1):76-80. doi: 10.1007/s001250051116.
5
Regression of left ventricular hypertrophy in hypertensive heart transplant recipients treated with enalapril, furosemide, and verapamil.接受依那普利、呋塞米和维拉帕米治疗的高血压心脏移植受者左心室肥厚的消退
Circulation. 1991 Aug;84(2):583-93. doi: 10.1161/01.cir.84.2.583.
6
Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.依那普利与美托洛尔对糖尿病肾病蛋白尿的对比作用。
BMJ. 1990 Apr 7;300(6729):904-7. doi: 10.1136/bmj.300.6729.904.
7
Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.血压控制对高血压合并2型糖尿病患者糖尿病微血管并发症的影响。
Diabetes Care. 2000 Apr;23 Suppl 2:B54-64.
8
Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.依那普利对伴有微量白蛋白尿的血压正常的糖尿病患者糖尿病肾病的预防作用
BMJ. 1988 Oct 29;297(6656):1092-5. doi: 10.1136/bmj.297.6656.1092.
9
The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.卡托普利对血压正常的微量白蛋白尿型胰岛素依赖型糖尿病患者糖尿病肾病的血管紧张素转换酶抑制作用。北美微量白蛋白尿研究组。
Am J Med. 1995 Nov;99(5):497-504. doi: 10.1016/s0002-9343(99)80226-5.
10
Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.依那普利和尼群地平对早期肾病的血压正常的I型糖尿病患者运动性蛋白尿的影响。
Horm Metab Res. 1996 Oct;28(10):549-52. doi: 10.1055/s-2007-979850.

引用本文的文献

1
Renoprotective role of ACE inhibitors in diabetic nephropathy.血管紧张素转换酶抑制剂在糖尿病肾病中的肾脏保护作用。
Br Heart J. 1994 Sep;72(3 Suppl):S38-45. doi: 10.1136/hrt.72.3_suppl.s38.
2
Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension.依那普利。对其药理学及在高血压治疗中的应用的重新评估。
Drugs. 1992 Mar;43(3):346-81. doi: 10.2165/00003495-199243030-00005.